Unusual Detection of Lathosterol in Amniotic Fluids Investigated for the Determination of Cholesterol and 7-Dehydrocholesterol for Suspected Smith-Lemli-Opitz Syndrome

The Smith-Lemli-Opitz syndrome (SLOS), is an autosomal recessive disorder caused by a 7-dehydrocholesterol reductase deficiency, which is characterized by abnormally elevated amniotic fluid 7-DHC (7-dehydrocholesterol) concentrations. A GC/FID (gas-chromatography with a flame ionization detector) and GC/MS (gas-chromatography with a mass detector) method was optimized for the detection of cholesterol and 7-DHC in amniotic fluids. The quantitative determination of cholesterol in 39 control amniotic fluids evidenced that between the fourth and fifth month of pregnancy the levels of this analyte are quite constant, the concentration of total and free cholesterol being respectively 10.3 μg·mL﹣1 (SD = ±3.6) and 1.7 μg·mL﹣1 (SD = ±0.91), while the analysis of 60 amniotic fluids potentially related to SLOS, showed a higher variability of cholesterol levels. Moreover, in 13 samples an analyte which did not correspond either to cholesterol or to 7-DHC was detected. A GC/MS investigation allowed us to identify this compound as lathosterol, a precursor of cholesterol in the biosynthetic pathway.

[1]  M. L. Cardoso,et al.  Quantitative analysis of five sterols in amniotic fluid by GC-MS: application to the diagnosis of cholesterol biosynthesis defects. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[2]  W. Griffiths,et al.  Potential of sterol analysis by liquid chromatography-tandem mass spectrometry for the prenatal diagnosis of Smith-Lemli-Opitz syndrome. , 2008, Clinical chemistry.

[3]  F. Chevy,et al.  Sterol profiling of amniotic fluid: a routine method for the detection of distal cholesterol synthesis deficit , 2005, Prenatal diagnosis.

[4]  F. Santorelli,et al.  Molecular studies in Portuguese patients with Smith-Lemli-Opitz syndrome and report of three new mutations in DHCR7. , 2005, Molecular genetics and metabolism.

[5]  A. Honda,et al.  Abnormal cholesterol biosynthesis in sitosterolaemia and the Smith-Lemli-Opitz syndrome , 1996, Journal of Inherited Metabolic Disease.

[6]  F. Porter.  Human malformation syndromes due to inborn errors of cholesterol synthesis. , 2003, Current opinion in pediatrics.

[7]  A. Hunter,et al.  Lathosterolosis: an inborn error of human and murine cholesterol synthesis due to lathosterol 5-desaturase deficiency. , 2003, Human molecular genetics.

[8]  F. Chevy,et al.  Molecular mechanisms underlying limb anomalies associated with cholesterol deficiency during gestation: implications of Hedgehog signaling. , 2003, Human molecular genetics.

[9]  A. Ballabio,et al.  Lathosterolosis, a Novel Multiple-Malformation/Mental Retardation Syndrome Due to Deficiency of 3β-Hydroxysteroid-Δ5-Desaturase , 2002 .

[10]  G. Herman,et al.  Inborn errors of sterol biosynthesis. , 2003, Annual review of genomics and human genetics.

[11]  H. J. Brink,et al.  A rapid screening procedure for cholesterol and dehydrocholesterol by electrospray ionization tandem mass spectrometry. , 2001, Journal of lipid research.

[12]  R. Steiner,et al.  Fetal demise with Smith–Lemli–Opitz syndrome confirmed by tissue sterol analysis and the absence of measurable 7‐dehydrocholesterol Δ7‐reductase activity in chorionic villi , 2000, Prenatal diagnosis.

[13]  A. Honda,et al.  Fetal Smith‐Lemli‐Opitz syndrome can be detected accurately and reliably by measuring amniotic fluid dehydrocholesterols , 1998, Prenatal diagnosis.

[14]  P. Clayton.  Disorders of cholesterol biosynthesis , 1998, Archives of disease in childhood.

[15]  T. Khong,et al.  FIRST‐TRIMESTER DIAGNOSIS OF SMITH–LEMLI–OPITZ SYNDROME , 1997, Prenatal diagnosis.

[16]  E. Naylor,et al.  Direct analysis of filter paper blood specimens for identification of Smith-Lemli-Opitz syndrome using time-of-flight secondary ion mass spectrometry. , 1997, American journal of medical genetics.

[17]  G. Tint,et al.  Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome. , 1995, The Italian journal of gastroenterology.

[18]  R. Giguere,et al.  Prenatal diagnosis of Smith-Lemli-Opitz syndrome is possible by measurement of 7-dehydrocholesterol in amniotic fluid. , 1995, Prenatal diagnosis.

[19]  R. Kelley.  Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[20]  R. Kelley,et al.  Prenatal detection of the cholesterol biosynthetic defect in the Smith-Lemli-Opitz syndrome by the analysis of amniotic fluid sterols. , 1995, American journal of medical genetics.

[21]  R. Kelley,et al.  Smith-Lemli-Opitz syndrome: prenatal diagnosis by quantification of cholesterol precursors in amniotic fluid. , 1995, American journal of medical genetics.

[22]  K. Mills,et al.  Prenatal diagnosis of Smith-Lemli-Opitz syndrome. , 1995, American journal of medical genetics.

[23]  A. Benninghoven,et al.  Smith-Lemli-Opitz syndrome diagnosed by using time-of-flight secondary-ion mass spectrometry. , 1995, Clinical chemistry.

[24]  M. Seller,et al.  Markedly increased tissue concentrations of 7-dehydrocholesterol combined with low levels of cholesterol are characteristic of the Smith-Lemli-Opitz syndrome. , 1995, Journal of lipid research.

[25]  G Salen,et al.  Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. , 1994, The New England journal of medicine.

[26]  G. Tint,et al.  Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome , 1993, The Lancet.